Prediction Case File
YouTubeEvaluation Complete

UnitedHealth Group Stock Prediction and Forecast [UNH]

1 extracted signal · 1 resolved · 0 still active

StockInvest.us profile imageStockInvest.usIndependent analyst profile
Source published
15 Nov 2025, 04:41 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for UnitedHealth Group Stock Prediction and Forecast [UNH]
Source overview

AI-generated source summary

The analysis of UnitedHealth Group (UNH) stock indicates a sell signal since October 30, 2025, with a score of -4.439. The stock has decreased by 6.64% since then, averaging a daily loss of 0.55%. The stock broke a rising short-term trend. Resistance is noted at $323.96. A reaction to this level would serve as a second opportunity to exit before declines. A three-month trend suggests a potential 11.12% change, ranging from 11.85% to 33.34%. Over the next 12 months, the forecast is for a 47.56% negative change, with a stock performance ranging from -$76.05 to -$45.12. Analyst ratings are mixed, with a general neutral rating. A stop-loss isn't given. There is a volume increase on falling prices, a warning signal. Target is $308.49.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
1
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
100%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

StockInvest.us

Platform-wide history, separate from this source evaluation.

Reliability
53.4
Tracked signals
1779
Historical success
42.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail